Dutta, Avik http://orcid.org/0000-0002-0368-2858
Nath, Dipmoy
Yang, Yue
Le, Bao T.
Rahman, Mohammad Ferdous-Ur
Faughnan, Patrick
Wang, Zhenjia
Stuver, Matthew
He, Rongquan
Tan, Wuwei
Hutchison, Robert E.
Foulks, Jason M.
Warner, Steven L.
Zang, Chongzhi http://orcid.org/0000-0003-4812-3627
Mohi, Golam http://orcid.org/0000-0002-7530-4784
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (R01 HL095685, R01 HL149893)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
U.S. Department of Defense (W81XWH1910280)
Article History
Received: 9 June 2021
Revised: 19 October 2021
Accepted: 21 October 2021
First Online: 5 November 2021
Competing interests
: G.M. received research funding from Tolero Pharmaceutical Inc. J.M.F. and S.L.W. are employees and stakeholders of Sumitomo Dainippon Pharma Oncology, Inc. (formerly known as Tolero Pharmaceuticals, Inc). The remaining authors declare no competing interests.